Assays / Heart
Heart
Myoglobin — Quantitative Fluorescent Assay
Myoglobin is planned as a supporting marker within OncoFirm’s multi-marker cardiac panel rather than as a stand-alone test.
At a glance
Target
Myoglobin (MYO)
Sample
Whole blood or plasma
Readout
Quantitative (planned)
Status
Planned, within the cardiac panel
Why it matters
Clinical context
Myoglobin rises early after muscle injury, but it is not specific to the heart, and current heart-attack guidelines center on troponin. OncoFirm therefore plans myoglobin as a companion value in the cardiac panel, reported next to troponin I.
How OncoFirm will measure it
Built on the OncoFirm fluorescent platform
Context next to troponin
Reporting myoglobin with cTnI on one strip is intended to give a fuller early picture without replacing troponin-based decisions.
A strip that checks itself
Every strip carries a fluorescent reference line of known brightness. Reading the test line against it corrects for reader and temperature drift, and the reader flags runs that did not flow correctly.
A traceable digital record
Each result is stored with the date, operator and lot, ready to share with a clinic record or laboratory system instead of being retyped by hand.
Where it's headed
Development roadmap
01
Feasibility
Antibody pairs, fluorescent conjugates and strip layout are selected and tested against the target.
02
Assay development
Strip, reagents and reader settings are optimized, and pilot lots are built.
03
Analytical validation
Precision, linearity, interference and lot-to-lot consistency are measured against reference methods.
04
Clinical evaluation and launch
Performance is evaluated with clinical samples. First release is planned for research use only, followed by regulatory submissions.
Related assays
Development status. This assay and the OncoFirm platform are in development. They have not been cleared or approved by the FDA and are not available for sale. First products are planned for research use only. Descriptions reflect design goals, not demonstrated performance.
Partner on this assay
We welcome research, clinical, manufacturing and distribution partners. Tell us how this assay fits your work.